Commentary: Vitamin C: Antioxidant or Pro-Oxidant In Vivo?

References

• Frei B., England L., Ames B. N. Ascorbate is an outstanding antioxidant in human blood plasma. Proceedings of the National Academy of Sciences of the LISA 1989; 86: 6377–6381
   PubMed Web of Science ®Google Scholar
• Sauberlich H. E. Pharmacology of vitamin C. Annual Review of Nutrition 1994; 14: 371–391
   PubMed Web of Science ®Google Scholar
• Burton G. W., Wronska U., Stone L., Foster D. O., Ingold K. U. Biokinetics of dietary RRR-tocopherol in the male guinea pig at three dietary levels of vitamin C and two levels of vitamin E. Evidence that vitamin C does not “spare” vitamin E in vivo. Lipids 1990; 25: 199–210
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 1989; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Packer J. E., Slater T. F., Willson R. L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979; 278: 737–738
   PubMed Web of Science ®Google Scholar
• Mukai K., Itoh S., Morimoto H. Stopped-flow kinetic study of vitamin E regeneration reaction with biological hydroquinones (reduced forms of ubiquinone, vitamin K and tocopherolquinone) in solution. Journal of Biological Chemistry 1992; 267: 22277–22281
   PubMed Web of Science ®Google Scholar
• Bisby R. H., Parker A. W. Reaction of ascorbate with the α-tocopheroxyl radical in micellar and bilayer membrane systems. Archives of Biochemistry and Biophysics 1995; 317: 170–178
   PubMed Web of Science ®Google Scholar
• Mehlhorn R. J., Sumida S., Packer L. Tocopheroxyl radical persistence and tocopherol consumption in liposomes and in vitamin E-enriched rat liver mitochondria and microsomes. Journal of Biological Chemistry 1989; 264: 13448–13452
   PubMed Web of Science ®Google Scholar
• Wefers H., Sies H. The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. European journal of Biochemistry 1988; 174: 353–357
   PubMedGoogle Scholar
• Liebler D. C., Kling D. S., Reed D. J. Antioxidant protection of phospholipid bilayers by α-tocopherol. Journal of Biological Chemistry 1986; 261: 12114–12119
   PubMed Web of Science ®Google Scholar
• Niki E., Saito T., Kawakami A., Kamiya Y. Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C. Journal of Biological Chemistry 1984; 259: 4177–4182
   PubMed Web of Science ®Google Scholar
• van den Berg J. J. M., Kuypers F. A., Roelofsen B., Op den Kamp J. A. F. The cooperative actions of vitamins E and C in the protection against peroxidation of parinaric acid in human erythrocyte membranes. Chemistry and Physics of Lipids 1990; 53: 309–320
   PubMed Web of Science ®Google Scholar
• Cadenas S., Lertsiri S., Otsuka M., Barja G., Miyazawa T. Phospholipid hydroperoxides and lipid peroxidation in liver and plasma of ODS rats supplemented with α-tocopherol and ascorbic acid. Free Radical Researcli 1996, in press
   PubMedGoogle Scholar
• Halliwell B., Gutteridge J. M. C. Free Radicals in Biology and Medicine, 2nd ed. Clarendon Press, Oxford 1989
   Google Scholar
• Halliwell B. How to characterize a biological antioxidant. Free Radical Research Communications 1990; 9: 1–32
   PubMed Web of Science ®Google Scholar
• Gutteridge J. M. C., Quinlan G. J. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochimica et Biophysica Acta 1992; 1159: 248–254
   PubMed Web of Science ®Google Scholar
• Halliwell B. J., Gutteridge M. C. The antioxidants of human extracellular fluids. Archives of Biochemistry and Biophysics 1990; 280: 1–8
   PubMed Web of Science ®Google Scholar
• Halliwell B., Hu M. L., Louie S., Duvall T. R., Tarkington B. R., Motchnik P., Cross C. E. Interaction of nitrogen dioxide with human plasma. Antioxidant depletion and oxidative damage. FEBS Letters 1992; 313: 62–66
   PubMed Web of Science ®Google Scholar
• Hu M. L., Louie S., Cross C. E., Motchnik P., Halliwell B. Antioxidant protection against hypo-chlorous acid in human plasma. Journal of Laboratory and Clinical Medicine 1992; 121: 257–262
   Google Scholar
• Frei B., Forte T. M., Ames B. N., Cross C. E. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Biochemical journal 1991; 247: 133–138
   Google Scholar
• Reznick A. Z., Cross C. E., Hu M., Suzuki Y. J., Khwaja S., Safadi A., Motchnik P. A., Packer L., Halliwell B. Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochemical journal 1992; 286: 607–611
   PubMed Web of Science ®Google Scholar
• Wiseman H., Halliwell B. Carcinogenic antioxidants: diethylstilboestrol, hexoestrol and 17 α-ethynyloestradiol. FEBS Letters 1993; 322: 159–163
   PubMedGoogle Scholar
• Roy D., Liehr J. G. Elevated 8-hydroxydeoxy-guanosine levels in DNA of diethylstilboestrol-treated syrian hamsters: covalent DNA damage by free radicals generated by redox cycling of diethylstilboestrol. Cancer Research 1991; 51: 3882–3885
   PubMed Web of Science ®Google Scholar
• Bielski B. H. J., Richter H. W. Some properties of the ascorbate free radical. Annals of the New York Academy of Sciences 1975; 258: 231–237
   PubMed Web of Science ®Google Scholar
• Buettner G. R. The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol and ascorbate. Archives of Biochemistry and Biophysics 1993; 300: 535–543
   PubMed Web of Science ®Google Scholar
• Halliwell B., Foyer C. H. Ascorbic acid, metal ions and the superoxide radical. Biochemical Journal 1976; 155: 697–700
   PubMed Web of Science ®Google Scholar
• Cabelli D. E., Bielski B. H. J. Kinetics and mechanism for the oxidation of ascorbic acid/ascorbate by HO2/O2- radicals. A pulse radiolysis and stopped-flow photolysis study. Journal of Physical Chemistry 1983; 87: 1809–1812
   Web of Science ®Google Scholar
• Nishikimi M. Oxidation of ascorbic acid with superoxide anion generated by the xanthine-xanthine oxidase system. Biochemical and Biophysical Research Communications 1975; 63: 463–68
   PubMed Web of Science ®Google Scholar
• Nandi A., Chatterjee I. B. Scavenging of superoxide radical by ascorbic acid. Journal of Bioscicnces 1987; 11: 435–441
   Web of Science ®Google Scholar
• Bendich A., Machlin L. J., Scandurra O., Burton G. W., Wayner D. D. M. The antioxidant role of vitamin C. Advances in Free Radical Biology and Medicine 1986; 2: 419–444
   Web of Science ®Google Scholar
• Wayner D. D. M., Burton G. W., Ingold K. U., Barclay L. R. C., Locke S. J. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochimica et Biophysica Acta 1987; 924: 408–419
   PubMed Web of Science ®Google Scholar
• Wayner D. D. M., Burton G. W., Ingold K. U. The antioxidant efficiency of vitamin C is concentration-dependent. Biochimica et Biophysica Acta 1986; 884: 119–123
   PubMed Web of Science ®Google Scholar
• Nihro Y., Miyataka H., Sudo T., Matsumoto H., Satoh T. 3-0-Alkylascorbic acids as free radical quenchers: synthesis and inhibitory effect on lipid peroxidation. Journal of Medicinal Chemistry 1991; 34: 2152–2157
   PubMed Web of Science ®Google Scholar
• Asmus K. D. Sulfur-centered free radicals. Radioprotectors and Anticarcinogens, T. F. Slater. Academic Press, London 1987; 23–42
   Google Scholar
• Sevilla M. D., Yan M., Becker D., Gillich S. ESR investigations of the reactions of radiation-produced thiyl and DNA peroxyl radicals: formation of sulfoxyl radicals. Free Radical Research Communications 1989; 6: 21–24
   Google Scholar
• Aruoma O. I., Halliwell B. Inactivation of a, -antiproteinase by hydroxyl radicals. The effect of uric acid. FEBS Letters 1989; 244: 76–80
   PubMed Web of Science ®Google Scholar
• Halliwell B., Wasil M., Grootveld M. Biologically-significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid. Implications for antioxidant protection in the inflamed rheumatoid joint. FEBS Letters 1987; 213: 15–18
   PubMed Web of Science ®Google Scholar
• Whiteman M., Halliwell B. Protection against peroxynitrite-dependent tyrosine nitration and α1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants. Free Radical Research 1996, in press
   PubMedGoogle Scholar
• Rice-Evans C., Okunade G., Khan R. The suppression of iron release from activated myoglobin by physiological electron donors and by desferrioxamine. Free Radical Research Communications 1989; 7: 45–54
   PubMed Web of Science ®Google Scholar
• Chou P. T., Khan A. U. L-ascorbic acid quenching of singlet delta molecular oxygen in aqueous media: generalized antioxidant property of vitamin C. Biochemical and Biophysical Research Communications 1983; 115: 932–937
   PubMed Web of Science ®Google Scholar
• Anbar M., Neta P. A compilation of specific bimolecular rate constants for the reaction of hydrated electrons, hydrogen atoms and hydroxyl radicals with inorganic and organic compounds in aqueous solution. International Journal of Applied Radiation and Isotopes 1987; 18: 493–523
   Google Scholar
• Chow C. K., Thacker R. R., Changchit C., Bridges R. B., Rehm S. R., Humble J., Turbek J. Lower levels of vitamin C and carotenes in plasma of cigarette smokers. Journal of the American College of Nutrition 1986; 5: 305–312
   PubMed Web of Science ®Google Scholar
• Cross C. E., van der Vliet A. C., O'Neill A., Louie S., Halliwell B. Oxidants, antioxidants and respiratory tract lining fluids. Environmental Health Perspectives 1994; 102(suppl 10)185–191
   PubMedGoogle Scholar
• Evans P. J., Cecchini R., Halliwell B. Oxidative damage to lipids and α1-antiproteinase by phenylbutazone in the presence of haem proteins. Protection by ascorbic acid. Biochemical Pharmacology 1992; 44: 981–984
   PubMedGoogle Scholar
• Evans P. J., Akanmu D., Halliwell B. Promotion of oxidative damage to arachidonic acid and α1-antiproteinase by anti-inflammatory drugs in the presence of the haem proteins myoglobin and cytochrome c. Biochemical Pharmacology 1994; 48: 2173–2179
   PubMed Web of Science ®Google Scholar
• Lehr H. A., Frei B., Olofsson A. M., Carew T. E., Arfors K. E. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 1995; 91: 1525–1532
   PubMed Web of Science ®Google Scholar
• Licht W. R., Tannenbaum S. R., Dean W. M. Use of ascorbic acid to inhibit nitrosation: kinetic and mass transfer considerations for an in vitro system. Carcinogenesis 1988; 9: 365–372
   PubMed Web of Science ®Google Scholar
• Udenfriend S., Clark C. T., Axelrod J., Brodie B. B. Ascorbic acid in aromatic hydroxylation. Journal of Biological Chemistry 1954; 208: 731–739
   PubMed Web of Science ®Google Scholar
• Wills E. D. Lipid peroxide formation in microsomes. The role of non-haem iron. Biochemical Journal 1969; 113: 325–332
   PubMed Web of Science ®Google Scholar
• Buettner G. R. Ascorbate autoxidation in the presence of iron and copper chelates. Free Radical Research Communications 1986; 1: 349–353
   PubMedGoogle Scholar
• Aruoma O. I., Halliwell B., Gajewski E., Dizdaroglu M. Copper ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. Biochemical journal 1991; 273: 601–604
   PubMed Web of Science ®Google Scholar
• Slivka A., Kang J., Cohen G. Hydroxyl radicals and the toxicity of oral iron. Biochemical Pharmacology 1986; 35: 553–556
   PubMed Web of Science ®Google Scholar
• Kadiiska M. B., Hanna P. M., Hernandez L., Mason R. P. In vivo evidence of hydroxyl radical formation after acute copper and ascorbic acid intake: electron spin resonance evidence. Molecular Pharmacology 1992; 42: 723–729
   PubMed Web of Science ®Google Scholar
• Maskos Z., Koppenol W. H. Oxyradicals and multivitamin tablets. Free Radical Biology and Medicine 1991; 11: 609–610
   PubMed Web of Science ®Google Scholar
• Orr C. W. M. Studies on ascorbic acid. I. Factors influencing the ascorbate-mediated inhibition of catalase. Biochemistry 1967; 6: 2995–3006
   PubMed Web of Science ®Google Scholar
• Shamberger R. J. Genetic toxicology of ascorbic acid. Mutation Research 1984; 133: 135–159
   PubMed Web of Science ®Google Scholar
• Andersson M., Grankvist K. Ascorbate-induced free radical toxicity to isolated islet cells. International Journal of Biochemistry and Cell Biology 1995; 27: 493–498
   PubMedGoogle Scholar
• Acedo G. N., Redei G. P., Sandhu S. S. Mutagenicity of ascorbic acid for the plant Arabidopsis. Mutation Research 1984; 129: 57–62
   Google Scholar
• De Laurenzi V., Melino G., Savini I., Annicchiarico-Petruzzelli M., Finazzi-Agro A., Avigliano L. Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines. European journal of Cancer 1995; 31A: 463–466
   PubMedGoogle Scholar
• Girotti A. W., Thomas J. P., Jordan J. E. Pro-oxidant and antioxidant effects of ascorbate on photosensitized peroxidation of lipids in erythrocyte membranes. Photochemistry and Photobiology 1985; 41: 267–276
   PubMed Web of Science ®Google Scholar
• Kao T. L., Meyer W. J., III, Post J. F. M. Inhibitory effects of ascorbic acid on growth of leukemic and lymphoma cell lines. Cancer Letters 1993; 70: 101–106
   PubMedGoogle Scholar
• Porter W. L. Paradoxical behaviour of antioxidants in food and biological systems. Toxicology and Industrial Health 1993; 9: 93–122
   PubMed Web of Science ®Google Scholar
• Retsky K. L., Freeman M. W., Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Journal of Biological Chemistry 1993; 268: 1304–1309
   PubMed Web of Science ®Google Scholar
• Retsky K. L., Frei B. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochimica et Biophysica Acta 1995; 1257: 279–287
   PubMed Web of Science ®Google Scholar
• Stait S. E.D., Leake S. Ascorbic acid: can either increase or decrease low density lipoprotein modification. FEBS Letters 1994; 341: 263–267
   PubMed Web of Science ®Google Scholar
• Smith C., Mitchinson M. J., Aruoma O. I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochemical journal 1992; 286: 901–905
   PubMed Web of Science ®Google Scholar
• Swain J., Gutteridge J. M. C. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Letters 1995; 368: 513–515
   PubMed Web of Science ®Google Scholar
• Evans P. J., Smith C., Mitchinson M. J., Halliwell B. Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. Free Radical Research 1995; 23: 465–469
   PubMed Web of Science ®Google Scholar
• Miller M., Hutchins G. M. Hemochromatosis, multi-organ hemosiderosis and coronary artery disease. Journal of the American Medical Association 1994; 272: 231–233
   Web of Science ®Google Scholar
• Araujo J. A., Romano E. L., Brito B. E., Parthe V., Romano M., Bracho M., Montano R. F., Cardier J. Iron overload augments the development of atherosclerotic lesions in rabbits. Arteriosclerosis, Thrombosis and Vascular Biology 1995; 15: 1172–1180
   PubMed Web of Science ®Google Scholar
• Sullivan J. L. Iron and the sex difference in heart disease risk. Lancet 1981; 1: 1293–1294
   PubMed Web of Science ®Google Scholar
• Crawford R. D. Proposed role for a combination of citric acid and ascorbic acid in the production of dietary iron overload: a fundamental cause of disease. Biochemical and Molecular Medicine 1995; 54: 1–11
   PubMedGoogle Scholar
• Liu P., Olivieri N. Iron overload cardiomyopathies: new insights into an old disease. Cardiovascular Drugs and Therapy 1994; 8: 101–110
   PubMed Web of Science ®Google Scholar
• Salonen J. T., Nyysonen K., Korpela H., Tuomilehto J., Seppanen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 1992; 86: 803–811
   PubMed Web of Science ®Google Scholar
• Hoffman K. E., Yanelli K., Bridges K. R. Ascorbic acid and iron metabolism: alterations in lysosomal function. American journal of Clinical Nutrition 1991; 54: 1188S–1192S
   PubMedGoogle Scholar
• Toth I., Bridges K. R. Ascorbic acid enhances ferritin mRNA translation by an IRP/aconitase switch. Journal of Biological Chemistry 1995; 270: 19540–19544
   PubMedGoogle Scholar
• Dorey C., Cooper C., Dickson D. P. E., Gibson J. F., Simpson R. J., Peters T. J. Iron speciation at physiological pH in media containing ascorbate and oxygen. British journal of Nutrition 1993; 70: 157–169
   PubMed Web of Science ®Google Scholar
• Block G. Vitamin C and cancer prevention: the epidemiologic evidence. American journal of Clinical Nutrition 1991; 53: 270S–282S
   PubMed Web of Science ®Google Scholar
• Dyke G. W., Craven J. L., Hall R., Garner R. C. Effect of vitamin C supplementation on gastric mucosal DNA damage. Carcinogenesis 1994; 15: 291–295
   PubMed Web of Science ®Google Scholar
• Gey F. Ten year retrospective on the antioxidant hypothesis of arteriosclerosis: threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. Journal of Nutritional Biochemistry 1995; 6: 206–236
   Web of Science ®Google Scholar
• Ocké M. C. Average intake of anti-oxidant (pro) vitamins and subsequent cancer mortality in the 16 cohorts of the seven countries study. International journal of Cancer 1995; 61: 480–484
   PubMed Web of Science ®Google Scholar
• Khaw K. T., Woodhouse P. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. British Medical Journal 1995; 310: 1559–1563
   PubMedGoogle Scholar
• Bergsten P., Amitai G., Kehrl J., Dhariwal K. R., Klein H. G., Levine M. Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes. Journal of Biological Chemistry 1990; 265: 2584–2587
   PubMed Web of Science ®Google Scholar
• Touati D. The molecular genetics of superoxide dismutase in E. coli. An approach to understanding the biological role and regulation of SODs in relation to other elements of the defence system against oxygen toxicity. Free Radical Research Communications 1989; 8: 1–9
   PubMed Web of Science ®Google Scholar
• Natvig D. O., Imlay K., Touati D., Hallewell R. A. Human copper-zinc superoxide dismutase complements superoxide dismutase-deficient Escherichia coli mutants. Journal of Biological Chemistry 1989; 262: 14697–14701
   Google Scholar
• Kuwai T., Nishikimi M., Ozawa T., Yagi K. A missense mutation of L-gulono-γ-lactone oxidase causes the inability of scurvy-prone osteogenic disorder rats to synthesise L-ascorbic acid. Journal of Biological Chemistry 1992; 267: 21973–21976
   PubMedGoogle Scholar
• Kimura H., Yamada Y., Morita Y., Ikeda H., Matsuo T. Dietary ascorbic acid depresses plasma and low density lipoprotein peroxidation in genetically scorbutic rats. Journal of Nutrition 1992; 122: 1904–1909
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radical Research 1996, in press
   Google Scholar
• Kunert K. J., Tappel A. L. The effect of vitamin C on in vivo lipid peroxidation in guinea pigs as measured by pentane and ethane production. Lipids 1983; 18: 271–274
   PubMed Web of Science ®Google Scholar
• Cailleux A., Allain P. Is pentane a normal constituent of human breath?. Free Radical Research Communications 1993; 18: 323–327
   PubMed Web of Science ®Google Scholar
• Mendis S., Sobotka P. A., Euler D. E. Expired hydrocarbons in patients with acute myocardial infarction. Free Radical Research 1995; 23: 117–122
   PubMed Web of Science ®Google Scholar
• Blake D. R., Hall N. D., Treby D. A., Halliwell B., Gutteridge J. M. C. Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clinical Science 1981; 61: 483–486
   PubMed Web of Science ®Google Scholar
• Lunec J., Blake D. R. The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis. Free Radical Research Communications 1985; 1: 31–39
   PubMedGoogle Scholar
• Cross C. E., Forte T., Stacker R., Louie S., Yamamoto Y., Ames B. N., Frei B. Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. Journal of Laboratory and Clinical Medicine 1990; 115: 396–404
   PubMed Web of Science ®Google Scholar
• Wells W. W., Xu D. P. Dehydroascorbate reduction. Journal of Bioenergetics and Biomembranes 1994; 26: 369–377
   PubMed Web of Science ®Google Scholar
• Meister A. On the antioxidant effects of ascorbic acid and glutathione. Biochemical Pharmacology 1992; 44: 1905–1915
   PubMed Web of Science ®Google Scholar
• Buettner G. R., Jurkiewicz B. A. Ascorbate free radical as a marker of oxidative stress: an EPR study. Free Radical Biology and Medicine 1993; 14: 49–55
   PubMed Web of Science ®Google Scholar
• Kunitano R., Miyauchi Y., Inoue M. Synthesis of a cytochrome c derivative with prolonged in vivo half-life and determination of ascorbyl radicals in the circulation of the rat. Journal of Biological Chemistry 1992; 267: 8732–8738
   PubMedGoogle Scholar
• Rowley D. A., Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds. FEBS Letters 1982; 138: 33–36
   PubMed Web of Science ®Google Scholar
• Rowley D. A., Halliwell B. Superoxide-dependent formation of hydroxyl radicals from NADH and NADPH in the presence of iron salts. FEBS Letters 1982; 142: 39–41
   PubMed Web of Science ®Google Scholar
• Rowley D. A., Halliwell B. Formation of hydroxyl radicals from NADH and NADPH in the presence of copper salts. Journal of Inorganic Biochemistry 1985; 23: 103–108
   PubMed Web of Science ®Google Scholar
• Milne L., Nicotera P., Orrenius S., Burkitt M. J. Effects of glutathione and chelating agents on copper-mediated DNA oxidation: pro-oxidant and antioxidant properties of glutathione. Archwes of Biochemistry and Biophysics 1993; 304: 102–109
   PubMed Web of Science ®Google Scholar
• Kanner J., Frankel E., Granit R., German B., Kinsella J. E. Natural antioxidants in grapes and wines. Journal of Agricultural and Food Chemistry 1994; 42: 64–69
   Web of Science ®Google Scholar
• Hertog M. G. L., Feskens E. J. M., Hollman P. C. H., Katan M. B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 1993; 342: 1007–1011
   PubMed Web of Science ®Google Scholar
• Laughton M. J., Halliwell B., Evans P. J., Hoult J. R. S. Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Biochemical Pharmacology 1989; 38: 2859–2865
   PubMed Web of Science ®Google Scholar
• Hodnick W. F., Kung F. S., Roettger W. J., Bohmont C. W., Pardini R. S. Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids. Biochemical Pharmacology 1986; 35: 2345–2357
   PubMed Web of Science ®Google Scholar
• Ahmed M. S., Ainley K., Parish J. H., Hadi S. M. Free radical-induced fragmentation of proteins by quercetin. Carcinogenesis 1994; 15: 1627–1630
   PubMedGoogle Scholar
• Sahu S. C., Washington M. C. Quercetin-induced lipid peroxidation and DNA damage in isolated rat-liver nuclei. Cancer Letters 1991; 58: 75–79
   PubMed Web of Science ®Google Scholar
• Canada A. T., Giannella E., Nguyen T. D., Mason R. P. The production of reactive oxygen species by dietary flavonols. Free Radical Biology and Medicine 1990; 9: 441–449
   PubMed Web of Science ®Google Scholar
• Fazal F., Rahman A., Greensill J., Ainley K., Hadi S. M., Parish J. H. Strand scission in DNA by quercetin and Cu(II): identification of free radical intermediates and biological consequences of scission. Carcinogenesis 1990; 11: 2005–2008
   PubMedGoogle Scholar
• Boyer R. F., McArthur J. S., Cary T. M. Plant phenolics as reductants for ferritin iron release. Phytochemistry 1990; 29: 3717–3719
   Google Scholar
• Shirahata S., Murakami H., Nishiyama K., Yamada K., Nonaka G., Nishioka I., Omura H. DNA breakage by flavan-3-ols and procyanidins in the presence of cupric ion. Agricultural and Food Chemistry 1989; 37: 299–303
   Google Scholar
• Sahu S. C., Gray G. C. Interactions of flavonoids, trace metals and oxygen: nuclear DNA damage and lipid peroxidation induced by myricetin. Cancer Letters 1993; 70: 73–79
   PubMed Web of Science ®Google Scholar
• Serafini A. Linus Pauling. A Man and His Science. Paragon House, New York 1991
   Google Scholar
• Cameron E., Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high dose ascorbic acid supplements in advanced human cancer. Chemico-Biological Interactions 1974; 9: 285–315
   PubMed Web of Science ®Google Scholar
• Moertel C. G. Megadoses of vitamin C are valuable in the treatment of cancer. Negative. Nutrition Reviews 1986; 44: 28–32
   PubMedGoogle Scholar
• Hemila H. Does vitamin C alleviate the symptoms of the common cold?-a review of current evidence. Scandinavian journal of Infectious Diseases 1994; 26: 1–6
   PubMed Web of Science ®Google Scholar
• Seshli M. A. Possible adverse health effects of vitamin C and ascorbic acid. Seminars in Oncology 1983; X: 299–304
   Google Scholar
• Hemila H., Herman Z. S. Vitamin C and the common cold: a retrospective analysis of Chalmers' review. Journal of the American College of Nutrition 1995; 14: 116–123
   PubMed Web of Science ®Google Scholar
• Moser U., Hornig D. High intakes of vitamin C: a contributor to oxalate formation in man?. Trends in Pharmacological Sciences 1982; 480–483
   Google Scholar
• Tsao C. S., Leung P. Y. Urinary ascorbic acid levels following the withdrawal of large doses of ascorbic acid in guinea pigs. Journal of Nutrition 1988; 118: 895–900
   PubMed Web of Science ®Google Scholar
• McLaran C. J., Bett J. H. N., Nye J. A., Halliday J. W. Congestive cardiomyopathy and haemochromatosis-rapid progression possibly accelerated by excessive ingestion of ascorbic acid. Australian and New Zealand journal of Medicine 1982; 12: 187–188
   PubMedGoogle Scholar
• Rowbotham B., Roeser H. P. Iron overload associated with congenital pyruvate kinase deficiency and high dose ascorbic acid ingestion. Australian and Neiv Zealand journal of Medicine 1984; 14: 667–669
   PubMedGoogle Scholar
• Ortwerth B. J., Slight S. H., Prabhakaram M., Sun Y., Smith J. B. Site-specific glycation of lens crys-tallins by ascorbic acid. Biochimica et Biophysica Acta 1992; 1117: 207–215
   PubMedGoogle Scholar
• Ortwerth B. J., Linetsky M., Olesen P. R. Ascorbic acid glycation of lens proteins produces UVA sensitizers similar to those in human lens. Photochemistry and Photobiology 1995; 62: 454–562
   PubMedGoogle Scholar
• Ortwerth B. J., Speaker J. A., Prabhakaram M., Lopez M. G., Li E. Y., Feather M. S. Ascorbic acid glycation: the reactions of L-threose in lens tissue. Experimental Eye Research 1994; 58: 665–674
   PubMed Web of Science ®Google Scholar
• Iwamato N., Kawaguchi T., Horikawa K., Nagakura S., Hidaka M., Kagimoto T., Takatsuki K., Nakakuma H. Haemolysis induced by ascorbic acid in paroxysmal nocturnal haemoglobinuria. Lancet 1994; 343: 357
   PubMed Web of Science ®Google Scholar
• Campbell G. D., Steinberg M. H., Bower J. D. Ascorbic acid-induced hemolysis in G-6-PD deficiency. Annals of Internal Medicine 1975; 82: 810
   PubMed Web of Science ®Google Scholar
• Mehta B., Singhal S. B., Mehta B. C. Ascorbic-acid-induced haemolysis in G-6-PD deficiency. Lancet 1990; 2: 944
   Google Scholar
• Taylor A. Cataract: relationships between nutrition and oxidation. Journal of the American College of Nutrition 1993; 12: 138–146
   PubMed Web of Science ®Google Scholar
• Bendich A., Langseth L. The health effects of vitamin C supplementation: a review. Journal of the American College of Nutrition 1995; 14: 124–136
   PubMed Web of Science ®Google Scholar
• Halliwell B., Dizdaroglu M. The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radical Research Communications 1992; 16: 75–87
   PubMed Web of Science ®Google Scholar
• Fucci L., Oliver C. N., Coon M. J., Stadtman E. R. Inactivation of key metabolic enzymes by mixed-function oxidation reactions: possible implication in protein turnover and ageing. Proceedings of the National Academy of Sciences of the USA 1983; 80: 1521–1525
   PubMed Web of Science ®Google Scholar
• Stadtman E. R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annual Review of Biochemistry 1993; 62: 797–821
   PubMed Web of Science ®Google Scholar
• Ames B. N., Shigenaga M. K., Hagen T. M. Oxidants, antioxidants and the degenerative diseases of aging. Proceedings of the National Academy of Sciences of the USA 1993; 90: 7915–7922
   PubMed Web of Science ®Google Scholar
• Totter J. R. Spontaneous cancer and its possible relationship to oxygen metabolism. Proceedings of the National Academy of Sciences of the USA 1980; 77: 1763–1767
   PubMed Web of Science ®Google Scholar
• Stremmel W., Riedel H. D., Niederau C., Strohmeyer G. Pathogenesis of genetic haemochromatosis. European Journal of Clinical Investigation 1993; 23: 321–329
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge J. M. C. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Archives of Biochemistry and Biophysics 1986; 246: 501–514
   PubMed Web of Science ®Google Scholar
• Cook J. D., Skikne B. S., Lynch S. R., Reusser M. E. Estimates of iron sufficiency in the US population. Blood 1986; 68: 726–731
   PubMed Web of Science ®Google Scholar
• Edwards C. O., Griffen L. M., Goldgar D., Drummond C., Skolnick M. H., Kushner J. P. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. New England Journal of Medicine 1988; 318: 1355–1362
   PubMed Web of Science ®Google Scholar
• Leggett B. A., Halliday J. W., Brown N. N., Bryant S., Powell L. W. Prevalence of haemochromatosis amongst asymptomatic Australians. British journal of Haematology 1990; 74: 525–530
   PubMed Web of Science ®Google Scholar
• Lynch S. R. Iron overload: prevalence and impact on health. Nutrition Reviews 1995; 53: 255–260
   PubMed Web of Science ®Google Scholar
• Hershko C., Graham G., Bates G. W., Rachmilewitz E. A. Non-specific serum iron in thalas-saemia: an abnormal serum iron fraction of potential toxicity. British Journal of Haematology 1978; 40: 255–263
   PubMed Web of Science ®Google Scholar
• Al-Refaie F. N., Wickens D. G., Wonke B., Kontoghiorghes G. J., Hoffbrand A. V. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and LI. British Journal of Haematology 1992; 82: 431–436
   PubMed Web of Science ®Google Scholar
• Laeng H., Egger T., Roethlisberger C., Cotter H. Stainable bone iron in undecalcified, plastic-embedded sections. Occurrence in Man related to the presence of “free” iron?. American Journal of Pathology 1988; 131: 344–350
   PubMedGoogle Scholar
• Heys A. D., Dormandy T. L. Lipid peroxidation in iron-overloaded spleens. Clinical Science 1981; 60: 295–301
   Web of Science ®Google Scholar
• Gutteridge J. M. C., Rowley D. A., Griffiths E., Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clinical Science 1985; 68: 463–467
   PubMed Web of Science ®Google Scholar
• Grootveld M., Bell J. D., Halliwell B., Aruoma O. I., Bomford A., Sadler P. J. Non-transferrin bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. Journal of Biological Chemistry 1989; 264: 4417–4422
   PubMed Web of Science ®Google Scholar
• Young I. S., Trouton T. G., Torney J. J., McMaster D., Callender M. E., Trimble E. R. Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radical Biology and Medicine 1994; 16: 393–397
   PubMed Web of Science ®Google Scholar
• von Herbay A., de Groot H., Hegi U., Stremmel W., Strohmeyer G., Sies H. Low vitamin E content in plasma of patients with alcoholic liver disease, haemochromatosis and Wilson's disease. Journal of Hematology 1994; 20: 41–46
   Google Scholar
• Nienhuis A. W. Vitamin C and iron. New England journal of Medicine 1981; 304: 170–171
   PubMed Web of Science ®Google Scholar
• Cohen A., Cohen I. J., Schwartz E. Scurvy and altered iron stores in thalassemia major. New England journal of Medicine 1981; 304: 158–160
   PubMed Web of Science ®Google Scholar
• George D. K., Evans R. M., Crofton R. W., Gunn I. R. Testing for haemochromatosis in the diabetic clinic. Annals of Clinical Biochemistry 1995; 32: 521–526
   PubMedGoogle Scholar
• Halliwell B., Cross C. E., Gutteridge J. M. C. Free radicals, antioxidants and human disease. Where are we now?. Journal of Laboratory and Clinical Medicine 1992; 119: 598–620
   PubMed Web of Science ®Google Scholar
• Moat N. E., Evans T. E., Quinlan G. J., Gutteridge J. M. C. Chelatable iron and copper can be released from extra-corporeally circulated blood during cardiopulmonary bypass. FEBS Letters 1993; 328: 103–106
   PubMed Web of Science ®Google Scholar
• Evans P. J., Evans R. W., Bomford A., Williams R., Halliwell B. Metal ions catalytic for free radical reactions in the plasma of patients with fulminant hepatic failure. Free Radical Research 1994; 20: 139–144
   PubMed Web of Science ®Google Scholar
• Rowley D. A., Gutteridge J. M. C., Blake D., Farr M., Halliwell B. Lipid peroxidation in rheumatoid arthritis: thiobarbituric-acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clinical Science 1984; 66: 691–695
   PubMed Web of Science ®Google Scholar
• Halliwell B., Aruoma O. I., Mufti G., Bomford A. Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs. FEBS Letters 1988; 241: 202–204
   PubMed Web of Science ®Google Scholar
• Gordeuk V. R., Brittenham G. M. Bleomycin-reactive iron in patients with acute non-lymphocytic leukemia. FEBS Letters 1992; 308: 4–6
   PubMed Web of Science ®Google Scholar
• Carmine T. C., Evans P., Bruchelt G., Evans R., Handgretinger R., Niethammer D., Halliwell B. Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management. Cancer Letters 1995; 94: 219–226
   PubMed Web of Science ®Google Scholar
• Moison R. M. W., Palinckx J. J. S., Roest M., Houdkamp E., Berger H. M. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993; 341: 79–82
   PubMed Web of Science ®Google Scholar
• Evans P. J., Evans R. W., Kovar I. Z., Horton A. F., Halliwell B. Bleomycin-detectable iron in the plasma of premature and full-term neonates. FEBS Letters 1992; 303: 210–212
   PubMed Web of Science ®Google Scholar
• Kaur H., Halliwel B. Aromatic hydroxyla-tion of phenylalanine as an assay for hydroxyl radicals. Measurement of hydroxyl radical formation from ozone and in blood from premature babies using improved HPLC methodology. Analytical Biochemistry 1994; 220: 11–15
   PubMed Web of Science ®Google Scholar
• Berger H. M., Mumby S., Gutteridge J. M. C. Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: implications for oxidative stress. Free Radical Research 1995; 22: 555–559
   PubMed Web of Science ®Google Scholar
• Burt M. J., Halliday J. W., Powell L. W. Iron and coronary heart disease. British Medical journal 1993; 307: 575–576
   PubMedGoogle Scholar
• Knekt P., Revnanen A., Takkunen H., Aromaa A., Heliovaara M., Hakulinen T. Body iron stores and risk of cancer. International journal of Cancer 1994; 56: 379–382
   PubMed Web of Science ®Google Scholar
• Sempos C. T., Looker A. C., Gillum R. F., Mauko D. M. Body iron stores and risk of coronary heart disease. New England Journal of Medicine 1994; 330: 1119–1124
   PubMed Web of Science ®Google Scholar
• Magnusson M. K., Sigfusson N., Sigvaldason H., Johannesson M., Magnusson S., Thorgeirsson G. Low iron binding capacity as a risk factor for myocardial infarction. Circulation 1994; 89: 102–108
   PubMed Web of Science ®Google Scholar
• Salonen J. T., Salonen R., Korpela H., Suntioinen S., Tuomikhto J. Serum copper and the risk of acute myocardial infarction; a prospective population study in men in Eastern Finland. American journal of Epidemiology 1991; 134: 268–276
   PubMed Web of Science ®Google Scholar
• Chevion M., Jiang Y., Har-El R., Berenshtein E., Uretzky G., Kitrossky N. Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proceedings of the National Academy of Sciences of the USA 1993; 90: 1102–1106
   PubMed Web of Science ®Google Scholar
• Bendich A., Cohen M. Ascorbic acid safety: analysis of factors affecting iron absorption. Toxicology Letters 1991; 51: 189–201
   Google Scholar
• Cook J. D., Watson S. S., Simpson K. M., Lipschitz D. A., Skikne B. S. The effect of high ascorbic acid supplementation on body iron stores. Blood 1984; 64: 721–726
   PubMed Web of Science ®Google Scholar
• Hunt J. R., Gallagher S. K., Johnson L. A. Effect of ascorbic acid on apparent iron absorption by women with low iron stores. American Journal of Clinical Nutrition 1994; 59: 1381–1385
   PubMed Web of Science ®Google Scholar
• Gey K. F., Moser U. K., Jordan P., Stahelin H. B., Eichholzer M., Liidin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. American journal of Clinical Nutrition 1993; 57(suppl)787S–797S
   PubMed Web of Science ®Google Scholar
• Fraga C. G., Motchnik P. A., Shigenaga M. K., Helbock H. J., Jacob R. A., Ames B. N. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proceedings of the National Academy of Sciences of the USA 1991; 88: 11003–11006
   PubMed Web of Science ®Google Scholar
• Jacob R. A., Kelley D. S., Pianalto F. S., Swendseid M. E., Henning S. M., Zhang J. Z., Ames B. N., Fraga C. S., Peters J. H. Immunocompetence and oxidant defense during ascorbate depletion of healthy men. American Journal of Clinical Nutrition 1991; 54: 1302S–1309S
   PubMed Web of Science ®Google Scholar
• Hunter D. J. A prospective study of the intake of vitamins C, E and A and the risk of breast cancer. New England Journal of Medicine 1993; 329: 234–240
   PubMed Web of Science ®Google Scholar
• Byers T., Perry G. Dietary carotenes, vitamin C, and vitamin E as protective agents in human cancers. Annual Review of Nutrition 1992; 12: 139–159
   PubMed Web of Science ®Google Scholar
• Blot W. J. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. Journal of the National Cancer Institute 1993; 85: 1483–1492
   PubMed Web of Science ®Google Scholar
• Sharer N. M., Taylor P. M., Linaher B. D., Gutteridge J. M. C., Braganza J. M. Safe and successful use of vitamin C to treat painful calcific chronic pancreatitis despite iron overload from primary haemochromatosis. Clinical Drug Investigation 1995; 10: 310–315
   Google Scholar
• Cohen M., Bhagavan H. N. Ascorbic acid and gastrointestinal cancer. Journal of the American College of Nutrition 1995; 14: 565–578
   PubMedGoogle Scholar
• Bergsten P. R.-Yu, Kehrl J., Levine M. Ascorbic acid transport and distribution in human B lymphocytes. Archives of Biochemistry and Biophysics 1995; 317: 208–214
   PubMedGoogle Scholar